Top Ten most popular articles on Pharmafile.com this week
September 29, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, EMA, FDA, HIV, J&J, JJ, Kevzara, Mylan, NICE, Sanofi, nash, top ten
It’s Friday, and it’s time for another round up of the most popular articles on pharmafile.com over the last seven …
Gilead’s COO retires, shares take a dive
September 29, 2017Medical Communications Gilead, Kevin Young, biotech, drugs, pharma, pharmaceutical
Gilead has announced that Kevin Young, its Chief Operating Officer, is set to retire from the company in early 2018. …
Makers of immediate-release opioids must fund training on their use, FDA says
September 29, 2017Medical Communications FDA, OxyContin, opioids, pharma, pharmaceuticals, vicodin
As part of its ongoing response to the opioid crisis in the US which is claiming the lives of over …
Lilly receives FDA breast cancer pill approval, doubts remain
September 29, 2017Medical Communications, Sales and Marketing Eli Lilly, Verzenio, biotech, drugs, pharma, pharmaceutical
Eli Lilly has received an important approval for its breast cancer treatment, Verzenio. The drug will be the third to …
Five more biosimilar-free years for AbbVie’s megablockbuster
September 28, 2017Medical Communications, Sales and Marketing AbbVie, Amgen, Amjevita, Humira, biotech, drugs, pharma, pharmaceutical
Humira is the key drug for AbbVie, and one the company hopes it will be able to push into the …
Novo Nordisk Egypt promotes new General Manager
September 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk, biotech, drugs, pharma, pharmaceutical
Novo Nordisk Egypt has promoted Hassan Fahmi to become its new General Manager for operations within the company. Fahmi arrived …
Rates of HIV rise amongst older population
September 28, 2017Medical Communications HIV, HIV test, biotech, drugs, pharma, pharmaceutical
It is rare to hear bad news in the fight against the spread of HIV, with the global campaign against …
Could the new EU Medical Devices Regulation put the UK MedTech industry in peril?
September 28, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing life sciences, medical devices, medical technology, medtech, medtech regulation, pharma, pharmaceutical
Gill Jennings and Every’s Fiona Stevens discusses recent developments in medical devices regulation and the subsequent impact on IP and …
Roche chalks up Swiss approval for multiple sclerosis drug Ocrevus
September 28, 2017Sales and Marketing Ocrevus, Roche, multiple sclerosis, pharma, pharmaceutical
Roche has announced that its drug Ocrevus (ocrelizumab) has received marketing approval in Switzerland for the treatment of active relapsing …
Sanofi and Regeneron’s projected blockbuster gains EU approval
September 28, 2017Sales and Marketing Dupixent, Regeneron, Sanofi, biotech, drugs, pharma, pharmaceutical
Sanofi and Regeneron have big hopes for their treatment Dupixent, and it has taken an important step towards reaching the …
29% of breast cancer trials do not establish control arm, study says
September 28, 2017Research and Development clinical trials, pharma, pharmaceutical
As part of the effort to conduct ethical and scientifically safe, effective clinical trials, the standard for researchers carrying out …
Measles eradicated in the UK, according to WHO
September 28, 2017Medical Communications UK, WHO, biotech, drugs, measles, pharma, pharmaceutical
The measles virus has been eliminated from the UK for the first time in the country’s history, according to the …
Roche’s Tecentriq scores approvals in metastatic lung and bladder cancer
September 27, 2017Research and Development, Sales and Marketing Cancer, EMA, EU, European Commission, Roche, bladder cancer, immunotherapy, lung cancer, pharma, tecentriq
It’s good news for Roche as the company’s immunotherapy drug Tecentriq secures approval from the European Commission to be used …
Improved heart attack test could save millions for NHS
September 27, 2017Research and Development biotech, drugs, heart attack, pharma, pharmaceutical
A new research, funded by the British Heart Foundation, has led to the creation of a new heart attack test …
EMA relocation will cause drug approval delays even in best case scenario, agency says
September 27, 2017Research and Development EMA, brexit, pharma, pharmaceuticals
As a direct result of the UK’s referendum vote to leave the EU last year, the headquarters of the EMA, …
Devastation to Puerto Rico threatens global medicine supply
September 27, 2017Medical Communications, Research and Development Puerto Rico, biotech, drugs, pharma, pharmaceutical
The destructive forces of Hurricane Maria have caused untold damage to the island nation, with a reported 13 people left …
Axovant shares capitulate after Alzheimer’s drug failure
September 26, 2017Research and Development Alzheimer's, Axovant, biotech, drugs, pharma, pharmaceutical
Axovant Sciences was set up with just one drug candidate in its portfolio, and a risky one, at that. The …
New CMO hops onto Bicycle Therapeutics
September 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Bicycle Therapeutics, GSK, Pfizer, biotech, drugs, pharma, pharmaceutical
Bicycle Therapeutics has moved to appoint industry veteran, Maria Koehler, to the position of Chief Medical Officer at the company. …
Allergan’s Executive VP and Chief Financial Officer steps down
September 26, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, appointment
Allergan has announced that its Executive Vice President and Chief Financial Officer Tessa Hilado intends to step down from her …
FDA pointedly rejects Intellipharma’s opioid painkiller
September 26, 2017Manufacturing and Production, Sales and Marketing FDA, Intellipharma, biotech, drugs, pharma, pharmaceutical
The FDA has been very public in its stance that it will look to gain the upper hand in bringing …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
